The epigenetic basis of the Warburg effect

Cancer development results from the accumulation of genetic and epigenetic changes. By interacting with intracellular signaling to promote carcinogenesis, epigenetic networks can actively transform cancer–promoting signals from tumor-permissive microenvironment to coordinate cellular proliferation and metabolism in the initiation and progression of cancers. As reported recently, NF-kappaB which can be activated by many soluble bioactive factors enriched in tumor microenvironments can promote the switch of cellular glucose metabolism from oxidative phosphorylation to oxygen-independent glycolysis in tumor cells, in addition to its well-known anti-apoptosis functions. Such epigenetic trans-generation of microenvironmental factors plays important roles in the development of cancers, particularly inflammation-related or sporadic cancers.

[1]  K. Kristiansen,et al.  HDAC Activity Is Required for p65/RelA-Dependent Repression of PPARδ-Mediated Transactivation in Human Keratinocytes , 2008 .

[2]  K. Aldape,et al.  Selective repression of YKL‐40 by NF‐κB in glioma cell lines involves recruitment of histone deacetylase‐1 and ‐2 , 2008, FEBS letters.

[3]  Zhong-ying Shen,et al.  Epigenetic silencing of a Ca2+-regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers , 2007, Proceedings of the National Academy of Sciences.

[4]  P. Laird Cancer epigenetics. , 2005, Human molecular genetics.

[5]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[6]  David Beach,et al.  Glycolytic enzymes can modulate cellular life span. , 2005, Cancer research.

[7]  David M. Berman,et al.  Tissue repair and stem cell renewal in carcinogenesis , 2004, Nature.

[8]  Sandy D. Westerheide,et al.  The p65 (RelA) Subunit of NF-κB Interacts with the Histone Deacetylase (HDAC) Corepressors HDAC1 and HDAC2 To Negatively Regulate Gene Expression , 2001, Molecular and Cellular Biology.

[9]  Matthias Schäfer,et al.  Cancer as an overhealing wound: an old hypothesis revisited , 2008, Nature Reviews Molecular Cell Biology.

[10]  Ralph J Deberardinis,et al.  Brick by brick: metabolism and tumor cell growth. , 2008, Current opinion in genetics & development.

[11]  J. Rathmell,et al.  New roles for pyruvate kinase M2: working out the Warburg effect. , 2008, Trends in biochemical sciences.

[12]  R. Deberardinis Is cancer a disease of abnormal cellular metabolism? New angles on an old idea , 2008, Genetics in Medicine.

[13]  Ru Wei,et al.  The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth , 2008, Nature.

[14]  Jun Yu,et al.  Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis , 2010, Oncogene.

[15]  R. Bjerkvig,et al.  Cancer initiation and progression: involvement of stem cells and the microenvironment. , 2007, Biochimica et biophysica acta.

[16]  Peter L. Jones,et al.  DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters , 2000, Nature Genetics.

[17]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[18]  M. Armoni,et al.  The Tumor Suppressor p 53 Down-Regulates Glucose Transporters GLUT 1 and GLUT 4 Gene Expression , 2004 .

[19]  Luke Hughes-Davies,et al.  DNA methyltransferase Dnmt1 associates with histone deacetylase activity , 2000, Nature Genetics.

[20]  K. Garber Energy boost: the Warburg effect returns in a new theory of cancer. , 2004, Journal of the National Cancer Institute.

[21]  Nobuyuki Tanaka,et al.  p53 regulates glucose metabolism through an IKK-NF-κB pathway and inhibits cell transformation , 2008, Nature Cell Biology.

[22]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.

[23]  A. Feinberg,et al.  The history of cancer epigenetics , 2004, Nature Reviews Cancer.

[24]  O. Warburg On the origin of cancer cells. , 1956, Science.

[25]  Peter A. Jones,et al.  Epigenetics in cancer. , 2010, Carcinogenesis.

[26]  Eyal Gottlieb,et al.  TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis , 2006, Cell.

[27]  Adrian Bird,et al.  Perceptions of epigenetics , 2007, Nature.

[28]  T. Kawabe,et al.  Decreased expression of the RAS-GTPase activating protein RASAL1 is associated with colorectal tumor progression. , 2009, Gastroenterology.

[29]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.

[30]  S. Baylin,et al.  DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci , 2000, Nature Genetics.